The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

“Cancer doesn’t respect borders, so why should we?” Watch this TEDx talk on cancer inequalities

November 27, 2019

In May this year, Professor Mark Lawler, a member of the EACR and IACR, gave a thought-provoking talk at TEDxQueensUniversityBelfast titled “Tackling Cancer Inequalities: The Time to Act is NOW!” He discussed being part of a collaboration of around 60 partners of cancer patients, patient advocates and healthcare professionals that helped to introduce the European Cancer Patient’s Bill of Rights on World Cancer Day in 2014.

There are three main principles of the Bill of Rights:

  • It is the right of every European citizen to receive the most accurate information and to be proactively involved in his/her care.
  • The right of every European citizen to optimal and timely access to a diagnosis and to appropriate specialised care, underpinned by research and innovation.
  • The right of every European citizen to receive care in health systems that ensure the best possible cancer prevention, the earliest possible diagnosis of their cancer, improved outcomes, patient rehabilitation, best quality of life and affordable health care.

Here are some key points from Professor Lawler’s passionate talk:

There are huge disparities within Europe with regards to survival rates, diagnosis, access to treatment and research & innovation.

  • In Poland, the lung cancer mortality rate is 83%, whereas the European average is 56.4%.
  • In Romania, the cervical cancer mortality rate is 14.2%, whereas the European average is 3.7%.
  • The survival rate is up to 40% higher in Western Europe compared to Eastern Europe.
  • This isn’t exclusive to Eastern Europe – in Northern Ireland, there was a ‘postcode lottery’ which saw some people in the UK miss out on access to innovative drugs.

“Cancer doesn’t respect borders, so why should we?”

  • The Bill of Rights has been signed by 25 different European countries, with 60 partners involved.
  • Research and innovation across borders: there are challenges with early diagnosis in the UK and Denmark. Danish research found ways to combat this, and this was shared with the UK
  • 87% of countries have a National Cancer Control Plan, which drops to 54% in Central & Eastern Europe. An aim of raising awareness and talking to politicians to change this statistic.

“The end of cancer treatment does not signal the end of cancer care”

  • Raising awareness that despite being cured, there are still the psycho-social, mental, emotional and financial affects of cancer that are often overlooked.
  • There are now more and more conferences and meetings catering for cancer survivors and cancer patients.
  • The Bill of Rights challenges inequalities that patients regularly experience.

70:35 vision – the aim that an average of a 70% long-term survival rate from cancer is achieved by 2035.

  • By working together and sharing best practice, this should be achievable.
  • Everyone can be involved! For example, Cancer Focus Northern Ireland helped to galvanise 30,000 signatures in an equal access campaign to demand improved access to innovative drugs and medicines.
  • Research and innovation is important: patients are more likely to have a better outcome if they are treated in a research hospital.
  • The Bill of Rights is a catalyst for change and a tool of empowerment for cancer patients.
Tags: collaborationEACR Membersnews summaryvideo

Related Posts

EACR-funded workshops help early-career researchers develop skills beyond the lab

EACR-funded workshops help early-career researchers develop skills beyond the lab

November 2, 2026

In September 2026, the EACR provided 68 funded places to EACR members across three dedicated workshops for early-career researchers, delivered virtually by EMBO Solutions. Focusing on...

EACR Travel Grant recipients at Liquid Biopsies 2026

EACR Travel Grant recipients at Liquid Biopsies 2026

November 2, 2026

We met in Lyon, France for the EACR Conference Liquid Biopsies between 22 and 24 September 2026. This EACR conference brought together world-leading experts and emerging investigators to...

Beyond Pink October: From Early Detection to Precision Breast Cancer Care

Beyond Pink October: From Early Detection to Precision Breast Cancer Care

October 28, 2026

This article was written by EACR members Sabrina Dhooge (Argentina) and Dr. Motahareh Rezvan (Iran), who connected through the EACR Member Network. Both involved in breast...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

EACR-funded workshops help early-career researchers develop skills beyond the lab
Career

EACR-funded workshops help early-career researchers develop skills beyond the lab

November 2, 2026
EACR Travel Grant recipients at Liquid Biopsies 2026
Career

EACR Travel Grant recipients at Liquid Biopsies 2026

November 2, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR